PC
Polar Capital Portfolio holdings
AUM
$13.5B
This Quarter Return
+6.66%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$8.75B
AUM Growth
+$8.75B
(+8.9%)
Cap. Flow
+$358M
Cap. Flow
% of AUM
4.09%
Top 10 Holdings %
Top 10 Hldgs %
24.38%
Holding
284
New
46
Increased
107
Reduced
75
Closed
35
Top Buys
| 1 |
Microsoft
MSFT
|
$97.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$65.6M |
| 3 |
Amazon
AMZN
|
$61.9M |
| 4 |
Nektar Therapeutics
NKTR
|
$60.8M |
| 5 |
Stryker
SYK
|
$57.2M |
Top Sells
| 1 |
PepsiCo
PEP
|
$77M |
| 2 |
Amgen
AMGN
|
$72.2M |
| 3 |
AET
Aetna Inc
AET
|
$69M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$52.8M |
| 5 |
CELG
Celgene Corp
CELG
|
$50.3M |
Sector Composition
| 1 | Financials | 23.81% |
| 2 | Healthcare | 22.43% |
| 3 | Technology | 21.12% |
| 4 | Communication Services | 11.68% |
| 5 | Industrials | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Aon
AON
$80.6B
| $40.3M | 0.42% |
300,800
-252,402
| -46% | -$33.8M |
|
|
SPLK
77
DELISTED
Splunk Inc
SPLK
| $40M | 0.41% |
482,510
-326,323
| -40% | -$27M |
|
78
Biogen
BIIB
$20.5B
| $39.3M | 0.41% |
123,413
+75,913
| +160% | +$24.2M |
|
|
LVNTA
79
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $38.6M | 0.4% |
711,177
-71,355
| -9% | -$3.87M |
|
|
AABA
80
DELISTED
Altaba Inc. Common Stock
AABA
| $36.4M | 0.38% |
520,520
+86,958
| +20% | +$6.07M |
|
81
Freeport-McMoran
FCX
$66.3B
| $36.2M | 0.37% |
1,906,905
-111,154
| -6% | -$2.11M |
|
82
NetEase
NTES
$85.4B
| $35.4M | 0.37% |
513,025
-11,250
| -2% | -$776K |
|
|
ANSS
83
DELISTED
Ansys
ANSS
| $35M | 0.36% |
237,346
+107,637
| +83% | +$15.9M |
|
84
Cigna
CI
$80.2B
| $34.5M | 0.36% |
170,000
| – | – |
|
|
OXFD
85
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $34.4M | 0.36% |
2,465,022
+100,000
| +4% | +$1.4M |
|
86
Icon
ICLR
$14B
| $33.8M | 0.35% |
301,330
-715
| -0.2% | -$80.2K |
|
|
MIME
87
DELISTED
Mimecast Limited
MIME
| $33.4M | 0.34% |
1,164,793
+190,589
| +20% | +$5.46M |
|
88
Universal Display
OLED
$6.61B
| $33.2M | 0.34% |
192,651
-172,491
| -47% | -$29.8M |
|
89
Aclaris Therapeutics
ACRS
$223M
| $33M | 0.34% |
1,339,931
-6,118
| -0.5% | -$151K |
|
90
Illumina
ILMN
$15.2B
| $32.8M | 0.34% |
154,470
| – | – |
|
91
Dynavax Technologies
DVAX
$1.19B
| $32.7M | 0.34% |
1,750,000
| – | – |
|
92
Labcorp
LH
$22.8B
| $32.6M | 0.34% |
238,004
+145,932
| +158% | +$20M |
|
93
Vertex Pharmaceuticals
VRTX
$102B
| $32.6M | 0.34% |
217,500
+101,000
| +87% | +$15.1M |
|
94
Penumbra
PEN
$10.5B
| $32.5M | 0.34% |
345,385
+11,755
| +4% | +$1.11M |
|
|
LEXEA
95
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $32.3M | 0.33% |
729,453
-1,757
| -0.2% | -$77.9K |
|
96
8x8 Inc
EGHT
$270M
| $31.9M | 0.33% |
2,263,884
+760,508
| +51% | +$10.7M |
|
97
Cognex
CGNX
$7.43B
| $31.4M | 0.32% |
514,072
-164,684
| -24% | -$10.1M |
|
98
Select Medical
SEM
$1.6B
| $31.3M | 0.32% |
3,292,260
+296,960
| +10% | +$2.82M |
|
99
Copa Holdings
CPA
$4.84B
| $30.8M | 0.32% |
229,967
-32,009
| -12% | -$4.29M |
|
100
JELD-WEN Holding
JELD
$520M
| $30.2M | 0.31% |
+767,729
| New | +$30.2M |
|